this issue
next article in this issue

Document Details :

Title: 18-fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours
Author(s): DE MAESENEER DJ, LAMBERT B, SURMONT V, GEBOES K, ROTTEY SWH
Journal: Acta Clinica Belgica
Volume: 65    Issue: 5   Date: 2010   
Pages: 291-299
DOI: 10.2143/ACB.65.5.1002427

Abstract :






Current response guidelines for the treatment of solid tumours are based on CT criteria. Over the last decades new techniques have emerged to evaluate cancer therapy. FDG-PET scanning is a more functional imaging technique, which can measure differences in metabolic activity. Although it has a low specificity, studies show that it can outperform classical CT scanning criteria. Especially in lung, breast and oesophageal cancer it can predict response earlier in the neo-adjuvant setting. This could reduce the use of ineffective cancer therapies, reducing costs and patient toxicity, and direct patients sooner towards effective therapy. The main problem with FDG-PET remains the difficulty in defining thresholds for response, as there is clearly a lack in large prospective randomized studies validating the use of FDG-PET in response guidelines. We give an overview of data on response prediction in solid tumours by the application of PET.